T1	LIVB 21 29	Paciente
#1	AnnotatorNotes T1	C0030705; Patients; Patient or Disabled Group
T2	PROC 45 53	consulta
#2	AnnotatorNotes T2	C0009818; Consultation; Health Care Activity
T3	PROC 57 74	Atención Primaria
#3	AnnotatorNotes T3	C0033137; Primary Health Care; Health Care Activity
T4	PROC 80 87	control
#4	AnnotatorNotes T4	C1522577; follow-up; Health Care Activity
T5	DISO 101 111	patologías
#5	AnnotatorNotes T5	C0677042; Pathology processes; Pathologic Function
T6	LIVB 133 138	Varón
T7	Age 142 149	55 años
T8	DISO 151 166	pluripatológico
T9	DISO 198 222	diabetes mellitus tipo 2
#6	AnnotatorNotes T9	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T10	Duration 226 232	8 años
T11	DISO 248 269	hipertensión arterial
#7	AnnotatorNotes T11	C0020538; Hypertensive disease; Disease or Syndrome
T12	Duration 273 287	más de 10 años
T13	DISO 303 313	dislipemia
#8	AnnotatorNotes T13	C0242339; Dyslipidemias; Disease or Syndrome
T14	DISO 316 341	isquemia arterial crónica
T15	Duration 334 341	crónica
T16	PROC 351 375	Tratamiento domiciliario
T17	CHEM 388 398	metformina
#9	AnnotatorNotes T17	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T18	Dose 399 404	850mg
T19	CHEM 407 417	gliclazida
#10	AnnotatorNotes T19	C0017631; gliclazide; Organic Chemical · Pharmacologic Substance
T20	Dose 418 422	30mg
T21	CHEM 425 434	enalapril
#11	AnnotatorNotes T21	C0014025; enalapril; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T22	CHEM 435 452	hidroclorotiazida
#12	AnnotatorNotes T22	C0020261; hydrochlorothiazide; Organic Chemical · Pharmacologic Substance
T23	Dose 453 462	20/12,5mg
T24	CHEM 465 487	ácido acetilsalicílico
#13	AnnotatorNotes T24	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T25	Dose 488 493	100mg
T26	CHEM 496 506	cilostazol
#14	AnnotatorNotes T26	C0055729; cilostazol; Organic Chemical · Pharmacologic Substance
T27	Dose 507 511	10mg
T28	Neg_cue 542 544	No
T29	Negated 545 552	refiere
T30	PROC 567 585	Exploración física
#15	AnnotatorNotes T30	C0031809; Physical Examination; Health Care Activity
T31	PHYS 610 620	consciente
#16	AnnotatorNotes T31	C0229994; Conscious mind; Mental Process | C0234421; Conscious; Mental Process
T32	PHYS 623 632	orientado
T33	ANAT 670 681	mucocutánea
#17	AnnotatorNotes T33	C4516595; Entire skin and mucous membrane; Body System
T34	PROC 684 686	TA
T35	PROC 701 706	Talla
T36	PROC 715 719	Peso
T37	PROC 728 731	IMC
T38	PROC 740 763	Pruebas complementarias
#18	AnnotatorNotes T38	C1515980; Ancillary Study; Research Activity
T39	PROC 765 774	Hemograma
#19	AnnotatorNotes T39	C0009555; Complete Blood Count; Laboratory Procedure | C0200631; Complete blood count without differential; Laboratory Procedure | C0852571; Blood counts NEC; Laboratory Procedure
T40	PROC 777 787	bioquímica
#20	AnnotatorNotes T40	C0201682; Chemical procedure; Laboratory Procedure | C0430027; biochemical test; Laboratory Procedure
T41	PROC 813 820	Glucosa
T42	PROC 833 849	colesterol total
#21	AnnotatorNotes T42	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T43	PROC 861 875	colesterol LDL
#22	AnnotatorNotes T43	C0202117; Low density lipoprotein cholesterol measurement; Laboratory Procedure
T44	Neg_cue 876 878	no
T45	Negated 879 889	calculable
T46	PROC 892 906	colesterol HDL
#23	AnnotatorNotes T46	C0392885; High density lipoprotein measurement; Laboratory Procedure
T47	PROC 917 930	triglicéridos
#24	AnnotatorNotes T47	C0202236; Triglycerides measurement; Laboratory Procedure
T48	PROC 942 965	Hemoglobina glicosilada
#25	AnnotatorNotes T48	C0202054; Glucohemoglobin measurement; Laboratory Procedure
T49	Neg_cue 979 982	sin
T50	DISO 983 995	alteraciones
#26	AnnotatorNotes T50	C0012634; Disease; Disease or Syndrome
T51	Negated 983 995	alteraciones
T52	PROC 1009 1020	TRATAMIENTO
#27	AnnotatorNotes T52	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T53	PROC 1035 1056	Se ajusta tratamiento
T54	CHEM 1070 1081	dulaglutida
#28	AnnotatorNotes T54	C3179549; dulaglutide; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T55	CHEM 1100 1107	fármaco
#29	AnnotatorNotes T55	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T56	LIVB 1111 1119	paciente
#30	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	DISO 1128 1143	pérdida de peso
#31	AnnotatorNotes T57	C1262477; Weight decreased; Finding
T58	Neg_cue 1206 1214	abandona
T59	Negated 1215 1222	tóxicos
T60	Frequency 1263 1269	diaria
T61	DISO 1297 1321	Diabetes Mellitus tipo 2
#32	AnnotatorNotes T61	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T62	DISO 1326 1348	mal control metabólico
T63	DISO 1350 1369	Síndrome metabólico
#33	AnnotatorNotes T63	C0524620; Metabolic Syndrome X; Disease or Syndrome
